Patents Assigned to Mpex Pharmaceuticals, Inc.
  • AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF
    Publication number: 20100040560
    Abstract: Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described.
    Type: Application
    Filed: October 22, 2009
    Publication date: February 18, 2010
    Applicant: MPEX PHARMACEUTICALS, INC.
    Inventors: Mark W. Surber, Keith A. Bostian, Michael N. Dudley, Olga Lomovskaya, David C. Griffith
  • AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF
    Publication number: 20100037890
    Abstract: Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described.
    Type: Application
    Filed: October 22, 2009
    Publication date: February 18, 2010
    Applicant: MPEX PHARMACEUTICALS, INC.
    Inventors: Mark W. Surber, Keith A. Bostian, Michael N. Dudley, Olga Lomovskaya (AKA Olga Rodny), David C. Griffith
  • POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF
    Publication number: 20080318957
    Abstract: Disclosed are compounds having polybasic functionalities. The compounds inhibit bacterial efflux pump inhibitors and are used in combination with an anti-bacterial agent to treat or prevent bacterial infections. These combinations can be effective against bacterial infections that have developed resistance to anti-bacterial agents through an efflux pump mechanism.
    Type: Application
    Filed: May 6, 2008
    Publication date: December 25, 2008
    Applicant: Mpex Pharmaceuticals, Inc.
    Inventors: TOMASZ GLINKA, Olga Lomovskaya, Keith Bostian, David M. Wallace